SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-008140
Filing Date
2021-01-13
Accepted
2021-01-13 16:08:58
Documents
2
Period of Report
2021-01-13

Document Format Files

Seq Description Document Type Size
1 6-K d51172d6k.htm 6-K 13441
2 EX-1.1 d51172dex11.htm EX-1.1 355337
  Complete submission text file 0001193125-21-008140.txt   369750
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 21526175
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences